NCT01807754

Brief Summary

This is a pilot, simulated breast cancer screening study. The goal of the study is to explore these scanning modalities: 1\) Combined digital breast tomosynthesis(DBT)/dual-sides 3 dimensional-automated ultrasound(AUS) 2\. Explore the utility of photoacoustic imaging as an adjunct to digital breast tomosynthesis(DBT)/ultrasound(US)alone.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2012

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

December 6, 2012

Completed
3 months until next milestone

First Posted

Study publicly available on registry

March 8, 2013

Completed
7.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 23, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 23, 2020

Completed
Last Updated

May 21, 2020

Status Verified

May 1, 2020

Enrollment Period

7.4 years

First QC Date

December 6, 2012

Last Update Submit

May 19, 2020

Conditions

Keywords

automated ultrasound imaging (AUS)digital breast tomosynthesis (DBT)photoacoustic imaging (PAT)

Outcome Measures

Primary Outcomes (1)

  • Evaluation of new breast imaging devices

    To determine if photoacoustic imaging is an adjunct to standard of care imaging with regards to quality of imaging. and ultrasound modalities and to determine if combining digital breast tomosynthesis and 3 dimensional automated ultrasound will result in a lower call-back ratio than imaging with digital breast tomosynthesis alone.

    3 years

Secondary Outcomes (1)

  • Determining the ratio of "patient call backs"

    5 years

Study Arms (1)

Imaging scans for breast cancer screening

To simulate the performance of the combination of three new breast imaging systems to digital mammography and hand-held ultrasound that are currently used to find and evaluate breast masses. These three different systems make images of the breast in several ways to find breast masses and to distinguish normal and abnormal masses. This may result in less unnecessary call-backs from mammography.

Procedure: X-ray and ultrasound imaging scanningProcedure: Photoacoustic imaging scans for breast cancer screening

Interventions

Digital tomosynthesis mammogram uses a low radiation dose, taking x-ray pictures of the breast from many angles to make a 3D(dimensional)image. The participant will be seated and her breast positioned as in a normal mammogram, though with reduced pressure. The x-ray tube will move quickly above the breast to take the images. Then, an ultrasound scan will be done using gel on your breast to assist in acquiring quality imaging.

Also known as: Digital tomosynthesis mammogram and automated ultrasound
Imaging scans for breast cancer screening

The participant will be seated in front of the laser device with the breast positioned on the laser device platform. Each subject will be given a laser protective eye mask/goggles to wear and will be instructed how to wear the mask/goggles during the scan. In addition pulse monitor leads may be placed on the participant's chest to allow the computer to record ultrasound blood flow in the breast. The low intensity laser light will be focused on the targeted area of the breast.

Also known as: Optoacoustic Imaging
Imaging scans for breast cancer screening

Eligibility Criteria

Age30 Years - 80 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population includes women who have had a mammogram at University of Michigan within one year who have been referred to the study. Participants may have a breast mass, either benign or cancerous.

You may qualify if:

  • Women with possible masses
  • All women should have had mammograms at University of Michigan Health System within 1 year before this research study.

You may not qualify if:

  • Women who are physically unable to tolerate the length of the scan.
  • Women who are less than 30 years of age or older than 80 years of age
  • Women who are pregnant or lactating
  • Women whose mass is in an area of the breast which makes it difficult to see in the research scans
  • Womens with a single diagnosis of mammographic calcifications
  • Women who have had a breast cancer with lumpectomy
  • Women who are prisoners
  • Women who are students or staff of investigators
  • Women who cannot give consent
  • Women with mammograms classified as probably benign because of follow-up of a recent benign biopsy.
  • Women with breast pain who have been categorized as BIRADS(Breast Imaging Reporting and Data System) category 0(incomplete) on their most recent mammograms.
  • Males, because their breast tissue is not easily imaged and numbers of potential cases are too few.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan Hospital

Ann Arbor, Michigan, 48109, United States

Location

MeSH Terms

Conditions

Breast CystBreast Neoplasms

Interventions

X-RaysHigh-Energy Shock Waves

Condition Hierarchy (Ancestors)

CystsNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesNeoplasms by Site

Intervention Hierarchy (Ancestors)

Electromagnetic RadiationElectromagnetic PhenomenaMagnetic PhenomenaPhysical PhenomenaRadiationRadiation, IonizingUltrasonic WavesSoundRadiation, Nonionizing

Study Officials

  • Paul L Carson, PhD

    Univ. of Michigan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 6, 2012

First Posted

March 8, 2013

Study Start

December 1, 2012

Primary Completion

April 23, 2020

Study Completion

April 23, 2020

Last Updated

May 21, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Locations